CASMED (CASM) to Announce First Quarter 2012 Financial Results and Hold Conference Call on May 8, 2012

BRANFORD, Conn., April 30, 2012 (GLOBE NEWSWIRE) — CAS Medical Systems, Inc. (Nasdaq:CASM) (CASMED) a leader in medical devices for non-invasive patient monitoring, today announced that it will report its financial results for the first quarter of 2012 on Tuesday, May 8^th prior to the market’s opening. Management will host a conference call to discuss these results and answer questions at 10:00 a.m. (ET) that day.

Conference call dial-in information is as follows:

• U.S. callers: (866) 239-5859
• International callers: (702) 495-1913

Individuals interested in listening to the live conference call via the Internet may do so by logging on to the Company’s website, www.casmed.com.

A telephone replay will be available from 11:00 a.m. (ET) on May 8, 2012, through 11:59 p.m. (ET) on May 15, 2012. Replay dial-in information is as follows:

• U.S. callers: (855) 859-2056
• International callers: (404) 537-3406
• Conference ID number (U.S. and international): 76917538
• The replay will also be available at www.casmed.com.

About CASMED® – Monitoring What’s Vital

CASMED is a leading developer and manufacturer of medical devices for non-invasive patient monitoring. The Company’s FORE-SIGHT Absolute Cerebral Oximeter is the only cerebral oximeter available with FDA clearance for non-invasive, continuous measurement of absolute cerebral tissue oxygen saturation for all patients, regardless of age or weight. Direct monitoring of tissue oxygenation provides a unique and powerful tool to alert clinicians to otherwise unrecognized and dangerously low levels of oxygenation of the brain and other tissues thereby allowing them to intervene appropriately in the care of their patients. In addition to FORE-SIGHT Oximeters and accessories, the Company provides a line of bedside patient vital signs monitoring products, proprietary non-invasive blood pressure monitoring solutions for OEM use, neonatal intensive care supplies, and service. CASMED products are designed to meet the needs of a full spectrum of patient populations worldwide, ranging from adults to pediatrics and neonates.

For further information regarding CASMED, visit the Company’s website at www.casmed.com.

CONTACT: Company Contacts
         CAS Medical Systems, Inc.
         Jeffery Baird
         Chief Financial Officer
         203-315-6303
         ir@casmed.com

         Investors
         LHA
         Kim Sutton Golodetz (kgolodetz@lhai.com)
         (212) 838-3777
         or
         Bruce Voss (bvoss@lhai.com)
         (310) 691-7100
         @LHA_IR_PR